Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations

被引：0
|
作者：
Ros Montana, F. J. [1 ]
Navarro, V. [2 ]
Comas, R. [2 ]
Landolfi, S. [3 ]
Ramirez, L. [4 ]
Palmer, H. G. [1 ]
Garcia Rodriguez, A. [1 ]
Saoudi Gonzalez, N. [1 ]
Baraibar Argota, I. [1 ]
Rodriguez Castells, M. [5 ]
Salva Ballabrera, F. [6 ]
Tabernero, J. [7 ]
Elez Fernandez, M. E. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[2] Vall dHebron Inst Oncol VHIO, Oncol Data Sci ODysSey Grp, Cellex Ctr, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[4] Vall dHebron Inst Oncol VHIO, Stem Cells Lab, Cellex Ctr, Barcelona, Spain
[5] Vall dHebron Inst Oncol VHIO, Med Oncol Dept, Cellex Ctr, Barcelona, Spain
[6] Vall dHebron Univ Hosp, Med Oncol Gastrointestinal Unit, Barcelona, Spain
[7] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1817
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
626P
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [21] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Roviello, Giandomenico
    D'Angelo, Alberto
    Petrioli, Roberto
    Roviello, Franco
    Cianchi, Fabio
    Nobili, Stefania
    Mini, Enrico
    Lavacchi, Daniele
    TRANSLATIONAL ONCOLOGY, 2020, 13 (09):
  • [22] The prognostic value of systemic inflammatory factors in BRAF (V600E) mutant metastatic colorectal cancer (mCRC).
    Martinez Lago, Nieves
    Covela Rua, Marta
    Brozos Vazquez, Elena
    Fernandez Montes, Ana Fernandez
    De la Camara Gomez, Juan Cruz
    Mendez Mendez, Carlos
    Jorge Fernandez, Monica
    Cousillas Castineira, Antia
    Grana Suarez, Begona
    Quintero Aldana, Guillermo Alfonso
    Candamio Folgar, Sonia
    Salgado Fernandez, Mercedes
    Pellon Augusto, Maria Luz
    Gonzalez Villarroel, Paula
    Gallardo Martin, Elena
    Carmona Campos, Marta
    Vazquez Rivera, Francisca
    Grande Ventura, Carlos
    Carral Maseda, Alberto
    Reboredo Lopez, Margarita
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [23] Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma
    Parakh, S.
    Murphy, C.
    Lau, D.
    Cebon, J. S.
    Andrews, M. C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (01) : 121 - 123
  • [24] BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
    Ros, Javier
    Baraibar, Iosune
    Sardo, Emilia
    Mulet, Nuria
    Salva, Francesc
    Argiles, Guillem
    Martini, Giulia
    Ciardiello, Davide
    Cuadra, Jose Luis
    Tabernero, Josep
    Elez, Elena
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [25] BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer-A Case Series Study Target Therapy of BRAF-Mutated mCRC
    Yeh, Jen-Hao
    Tsai, Hsiang-Lin
    Chen, Yen-Cheng
    Li, Ching-Chun
    Huang, Ching-Wen
    Chang, Tsung-Kun
    Su, Wei-Chih
    Chen, Po-Jung
    Liu, Yu-Peng
    Wang, Jaw-Yuan
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [26] Therapie des BRAF-V600E-mutierten kolorektalen Karzinoms im metastasierten StadiumTreatment of metastatic BRAF V600E mutated colorectal carcinoma
    Aylin Pamuk
    Thomas Zander
    Hakan Alakus
    Christiane Bruns
    Der Onkologe, 2020, 26 (3): : 292 - 294
  • [27] PROLONGED SURVIVAL OF A PATIENT WITH BRAF-V600E MUTATED PAEDIATRIC GLIOSARCOMA TREATED BY REPEATED SAFE SURGICAL RESECTION, FOCAL IRRADIATION, TEMOZOLOMIDE AND DUAL BRAF / MEK INHIBITORS
    Ku, Dennis T. L.
    Liu, Anthony P. Y.
    SimYan, Carol Lai
    Fu, Eric Chun Ho
    Yau, Jeffrey Ping Wa
    Shing, Matthew Ming Kong
    Luk, Chung Wing
    Chan, Godfrey Chi-Fung
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S615 - S615
  • [28] Activity of EGFR inhibition in atypical (non-V600E) BRAF-mutated metastatic colorectal cancer
    Johnson, Benny
    Loree, Jonathan M.
    Morris, Van K.
    Dasari, Arvind
    Pant, Shubham
    Raghav, Kanwal Pratap Singh
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [29] Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases
    Buchanan, Daniel D.
    Win, Aung K.
    Walsh, Michael D.
    Walters, Rhiannon J.
    Clendenning, Mark
    Nagler, Belinda
    Pearson, Sally-Ann
    Macrae, Finlay A.
    Parry, Susan
    Arnold, Julie
    Winship, Ingrid
    Giles, Graham G.
    Lindor, Noralane M.
    Potter, John D.
    Hopper, John L.
    Rosty, Christophe
    Young, Joanne P.
    Jenkins, Mark A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 917 - 926
  • [30] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer Reply
    Kopetz, Scott
    Grothey, Axel
    Tabernero, Josep
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 877 - 878
12345